Alignment Healthcare Inc (NASDAQ: ALHC) has experienced a decline in its stock price by -0.15 compared to its previous closing price of 6.87. However, the company has seen a gain of 31.42% in its stock price over the last five trading days. Seeking Alpha reported 2024-05-04 that Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants John Kao – Founder and Chief Executive Officer Thomas Freeman – Chief Financial Officer Conference Call Participants Nathan Rich – Goldman Sachs Ryan Daniels – William Blair John Ransom – Raymond James Adam Ron – Bank of America Whit Mayo – Leerink Partners Jess Tassan – Piper Sandler John Ransom – Raymond James Operator Good afternoon, and welcome to Alignment Healthcare’s First Quarter 2024 Earnings Conference Call and Webcast. [Operator Instructions] Please note that this event is being recorded.
Is It Worth Investing in Alignment Healthcare Inc (NASDAQ: ALHC) Right Now?
The 36-month beta value for ALHC is at 1.31. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ALHC is 90.98M, and currently, shorts hold a 5.16% of that float. The average trading volume for ALHC on May 08, 2024 was 1.01M shares.
ALHC’s Market Performance
ALHC stock saw an increase of 31.42% in the past week, with a monthly gain of 42.62% and a quarterly increase of 6.85%. The volatility ratio for the week is 8.17%, and the volatility levels for the last 30 days are 5.40% for Alignment Healthcare Inc (ALHC).. The simple moving average for the past 20 days is 29.59% for ALHC’s stock, with a 6.19% simple moving average for the past 200 days.
Analysts’ Opinion of ALHC
Barclays, on the other hand, stated in their research note that they expect to see ALHC reach a price target of $4.50. The rating they have provided for ALHC stocks is “Underweight” according to the report published on March 06th, 2024.
Piper Sandler gave a rating of “Neutral” to ALHC, setting the target price at $6 in the report published on March 06th of the current year.
ALHC Trading at 32.66% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.41% of loss for the given period.
Volatility was left at 5.40%, however, over the last 30 days, the volatility rate increased by 8.17%, as shares surge +45.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.14% lower at present.
During the last 5 trading sessions, ALHC rose by +32.38%, which changed the moving average for the period of 200-days by +11.81% in comparison to the 20-day moving average, which settled at $5.40. In addition, Alignment Healthcare Inc saw -20.33% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from Maroney Dawn Christine, who sale 10,151 shares at the price of $4.84 back on Mar 28 ’24. After this action, Maroney Dawn Christine now owns 1,976,097 shares of Alignment Healthcare Inc, valued at $49,131 using the latest closing price.
Kardes Hakan, the Chief Experience Officer of Alignment Healthcare Inc, sale 4,363 shares at $4.84 during a trade that took place back on Mar 28 ’24, which means that Kardes Hakan is holding 430,444 shares at $21,117 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.11 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.08. The total capital return value is set at -0.45. Equity return is now at value -88.91, with -22.55 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at -0.93. The debt to equity ratio resting at 1.24. The interest coverage ratio of the stock is -6.31.
Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 0.62. When we switch over and look at the enterprise to sales, we see a ratio of 0.62. The receivables turnover for the company is 12.2for trailing twelve months and the total asset turnover is 3.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.57.
Conclusion
In conclusion, Alignment Healthcare Inc (ALHC) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
